https://ift.tt/pnED7n
Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers seeking answers as to why the nearly 100-year-old drug has become unaffordable for many diabetics across the country.
Read more
0 comments:
Post a Comment